dCK Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of dCK Antibodies for research in cellular metabolism and nucleoside salvage pathways. dCK Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Deoxycytidine kinase (dCK) plays a crucial role in the phosphorylation of deoxynucleosides, which is essential for DNA synthesis and repair. dCK is particularly significant in cancer therapy, as it activates nucleoside analogs used in chemotherapy. Research focusing on dCK has revealed its importance in cell survival and proliferation. Understanding dCK function and regulation can provide insights into therapeutic strategies and resistance mechanisms in cancer treatment. Investigating dCK expression patterns helps researchers identify potential therapeutic targets in various cancers. Current studies explore how dCK influences DNA repair pathways and cellular response to chemotherapy. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of dCK and its impact on cancer treatment strategies.